Abstract
Summary
The effects of the age at estrogen replacement therapy (ERT) initiation on bone quality in Turner syndrome were evaluated using trabecular bone score. Early puberty ERT positively correlated with increase in bone quality. Early initiation of ERT is necessary for the acquisition of bone quality as well as bone density.
Introduction
Studies have reported associations between bone mineral density and estrogen replacement therapy (ERT) in Turner syndrome (TS) patients; however, few studies exist on the effect on bone quality. The aim of this study was to evaluate the effects of the age at ERT initiation on bone quality of Japanese TS patients, cross-sectionally and longitudinally.
Methods
Cross-sectionally, 95 TS patients were divided into three groups based on their age at initiation of ERT: A (12–14 years, 11 patients), B (15–17 years, 47 patients), and C (over 18 years, 37 patients). To assess bone quality, trabecular bone score (TBS) was used. The effects of age at initiation and duration of ERT on TBS were examined using multiple regression analysis. In the longitudinal study, 48 patients who underwent dual-energy X-ray absorptiometry multiple times were divided into three groups: D (12–14 years, 8 patients), E (15–17 years, 18 patients), and F (over 18 years, 22 patients). Each group was analyzed for the rate of change in TBS per year.
Results
Cross-sectionally, the TBS showed significant differences among the three groups (TBS A, 1.302; B, 1.299; C, 1.245) (p = 0.013); group C was significantly lower than B (p = 0.014); bone quality was degraded. Multiple regression analysis revealed that age at ERT initiation significantly affected the increase in TBS (p = 0.002). Longitudinally, the rate of change of TBS was not significantly different in the three groups (p = 0.73).
Conclusion
Early initiation of ERT may have positive effects on bone quality in TS. Large prospective studies will be needed.
Similar content being viewed by others
Data availability
The datasets analyzed during this study are available from the corresponding author on reasonable request.
References
Bondy CA, Turner Syndrome Study Group (2007) Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92:10–25
Wolff DJ, Van Dyke DL, Powell CM (2010) Laboratory guideline for Turner syndrome. Genet Med 12:52–55
Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G (1997) Spontaneous pubertal development in Turner’s Syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab 82:1810–1813
Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ (1982) Skeletal demineralization in Turner's syndrome. Calcif Tissue Int 34:519–522
Davies MC, Gulekli B, Jacobs HS (1995) Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clin Endocrinol 43:741–746
Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS (2003) Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol 59:89–96
Manolagas SC, O'Brien CA, Almeida M (2013) The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol 9:699–712
Soucek O, Schönau E, Lebl J, Willnecker J, Hlavka Z, Sumnik Z (2018) A 6-year follow-up of fracture incidence and volumetric bone mineral density development in girls with Turner syndrome. J Clin Endocrinol Metab 103:1188–1197
Hansen MA, Overgaard K, Riis BJ, Christiansen C (1991) Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 303:961–964
Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C (1996) Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study. Bone 19:9–12
Nakamura T, Tsuburai T, Tokinaga A, Nakajima I, Kitayama R, Imai Y, Nagata T, Yoshida H, Hirahara F, Sakakibara H (2015) Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome. Endocr J 62:965–970
Nguyen HH, Wong P, Strauss BJ, Jones G, Ebeling PR, Milat F, Vincent A (2017) Delay in estrogen commencement is associated with lower bone mineral density in Turner syndrome. Climacteric 20:436–441
Kodama M, Komura H, Kodama T, Nishio Y, Kimura T (2012) Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients. Endocr J 59:153–159
Cameron-Pimblett A, Davies MC, Burt E, Talaulikar VS, La Rosa C, King TFJ, Conway GS (2019) Effects of estrogen therapies on outcomes in Turner syndrome: assessment of induction of puberty and adult estrogen use. J Clin Endocrinol Metab 104:2820–2826
Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE, Sas TCJ, Silberbach M, Söderström-Anttila V, Stochholm K, van Alfen-van derVelden JA, Woelfle J, Backeljauw PF (2017) Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol 177:G1–G70
Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD Official Positions Part 2: trabecular bone score. J Clin Densitom 18:309–330
Bouxsein ML (2005) Determinants of skeletal fragility. Best Pract Res Clin Rheumatol 19:897–911
McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H, Barkmann R, Boutroy S, Brown J, Chapurlat R, Elders PJM, Fujita Y, Glüer CC, Goltzman D, Iki M, Karlsson M, Kindmark A, Kotowicz M, Kurumatani N, Kwok T, Lamy O, Leung J, Lippuner K, Ljunggren Ö, Lorentzon M, Mellström D, Merlijn T, Oei L, Ohlsson C, Pasco JA, Rivadeneira F, Rosengren B, Sornay-Rendu E, Szulc P, Tamaki J, Kanis JA (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 31:940–948
Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769
Harvey NC, Glüer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C, Kendler D, Lamy O, Laslop A, Camargos BM, Reginster JY, Rizzoli R, Kanis JA (2015) Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78:216–224
Nguyen HH, Wong P, Strauss BJ, Ebeling PR, Milat F, Vincent A (2018) A cross-sectional and longitudinal analysis of trabecular bone score in adults with Turner syndrome. J Clin Endocrinol Metab 103:3792–3800
Nour MA, Burt LA, Perry RJ, Stephure DK, Hanley DA, Boyd SK (2016) Impact of growth hormone on adult bone quality in Turner syndrome: a HR-pQCT study. Calcif Tissue Int 98:49–59
Barthe N, Braillon P, Ducassou D, Basse-Cathakinat B (1997) Comparison of two Hologic DXA systems (QDR 1000 and QDR 4500/A). Br J Radiol 70:728–739
Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337
Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530
Cintron D, Rodriguez-Gutierrez R, Serrano V, Latortue-Albino P, Erwin PJ, Murad MH (2017) Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with turner syndrome: a systematic review and meta-analysis. Endocrine 55:366–375
Tritos NA, Klibanski A (2016) Chapter Nine – Effects of growth hormone on bone. in. Prog Mol Biol Transl Sci 138:193–211
Kužma M, Killinger Z, Jackuliak P, Vaňuga P, Hans D, Binkley N, Payer J (2019) Pathophysiology of growth hormone secretion disorders and their impact on bone microstructure as measured by trabecular bone score. Physiol Res 68:S121–S129
Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D (2018) Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial. Osteoporos Int 29:323–328
McClung MR, Lippuner K, Brandi ML, Zanchetta JR, Bone HG, Chapurlat R, Hans D, Wang A, Zapalowski C, Libanati C (2017) Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. Osteoporos Int 28:2967–2973
Shawwa K, Arabi A, Nabulsi M, Maalouf J, Salamoun M, Choucair M, Hans D, El-Hajj Fuleihan G (2016) Predictors of trabecular bone score in school children. Osteoporos Int 27:703–710
Dowthwaite JN, Winzenrieth R, Binkley N, Krueger D, Scerpella TA (2017) A focused evaluation of lumbar spine trabecular bone score in the first year post-menarche. Arch Osteoporos 12:90
Donaldson AA, Feldman HA, O'Donnell JM, Gopalakrishnan G, Gordon CM (2015) Spinal bone texture assessed by trabecular bone score in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 100:3436–3442
Levy-Shraga Y, Tripto-Shkolnik L, David D, Vered I, Stein D, Modan-Moses D (2019) Low trabecular bone score in adolescent female inpatients with anorexia nervosa. Clin Nutr 38:1166–1170
Acknowledgments
This work was conducted independently without financial support from companies or funds. We wish to acknowledge Yokohama City University Medical Center and all Turner Syndrome patients who participated in the study. We wish to thank Assistant Professor Dr. Toshihiro Misumi from the Department of Biostatistics, Yokohama City University for providing appropriate advice in statistical analysis.
Funding
This work was conducted independently without financial support from companies or funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval for this study was obtained from the Ethics Committees of Yokohama City University School of Medicine (IRB number: B190300010).
Consent to participate
Informed consent for publication was obtained from all individual participants included in the study.
Code availability
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Saito, S., Koga, E., Okada, Y. et al. Effects of age at estrogen replacement therapy initiation on trabecular bone score in Japanese adults with Turner syndrome. Osteoporos Int 32, 671–680 (2021). https://doi.org/10.1007/s00198-020-05652-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-020-05652-1